Hartford Healthcare Cancer Institute @ Hartford Hospital

Hartford, Connecticut 06102

Use our guide to learn which trials are right for you!

We've found
8 trials
at this facility
Oncology, Other Clinical Trial
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Hartford, CT
Click here to add this to my saved trials
Negative-Pressure Wound Therapy Clinical Trial
Negative Pressure Wound Therapy in Post-Operative Incision Management
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Hartford, CT
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Hartford, CT
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Hartford, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Genomic Profiling in Cancer Patients
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Hartford, CT
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Hartford, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 12/31/1969
mi
from
Hartford, CT
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Hartford, CT
Click here to add this to my saved trials